Is 3-PPP a potential antipsychotic agent? Evidence from animal behavioural studies-Reference-Cited by-同舟云学术

Is 3-PPP a potential antipsychotic agent? Evidence from animal behavioural studies

Published:1982-09 Issue:1-2 Volume:83 Page:131-134
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Clark David,Carlsson Arvid,Hjorth Stephan,Svensson Kjell,Engel Jörgen,Sanchez Domingo

Publisher

Elsevier BV

Subject

Pharmacology

Reference10 articles.

1. Antipsychotic drugs and central dopaminergic neurons: A model for predicting therapeutic efficacy and incidence of extrapyramidal side effects;Bunney,1975

2. Blockage of amphetamine induced motor stimulation and stereotype in the adult rat following neonatal treatment with 6-hydroxydopamine;Creese;Brain Res.,1973

3. Behavioral actions of neuroleptics;Fielding,1978

4. 3-PPP, a new centrally acting DA-receptor agonist with selectivity for autoreceptors;Hjorth;Life Sci.,1981

5. Dopamine in the basal ganglia. Its role and therapeutic implications;Hornykiewicz;Br. Med. Mull.,1973

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aripiprazole has Functionally Selective Actions at Dopamine D2 Receptor-Mediated Signaling Pathways;Neuropsychopharmacology;2006-03-22

2. Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia;Nature Reviews Drug Discovery;2004-04

3. Aripiprazole: a partial dopamine D2 receptor agonist antipsychotic;Expert Opinion on Investigational Drugs;2003-04

4. Antipsychotic Agents;Burger's Medicinal Chemistry and Drug Discovery;2003-01-15

5. Aripiprazole, a novel antipsychotic drug, inhibits quinpriole-evoked GTPase activity but does not up-regulate dopamine D2 receptor following repeated treatment in the rat striatum;European Journal of Pharmacology;1997-02